SCHEMBL11160077

SCHEMBL11160077

CN1CCc2cc(O)cc(Sc3ccccc3)c2CC1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ DRD1 P21728 13/20 0.46
▸ DRD2 P14416 11/20 0.46
▸ DRD5 P21918 11/20 0.46
▸ DRD3 P35462 10/20 0.46
▸ DRD4 P21917 6/20 0.46
▸ CHRNA7 P36544 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.40
▸ NPY1R P25929 1/20 0.40
▸ NPY2R P49146 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ ADRA2C P18825 1/20 0.40
▸ ADRA1D P25100 1/20 0.40
▸ ADRA1A P35348 1/20 0.40
▸ ADRA1B P35368 1/20 0.40
▸ HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11162576 0.81 DRD1 (0.48) DRD1DRD2DRD5DRD3DRD4
SCHEMBL11038468 0.79 ADRA2A (0.51) DRD1DRD2DRD5DRD3DRD4
SCHEMBL10701215 0.78 DRD1 (0.53) DRD1DRD2DRD5DRD3DRD4
SCHEMBL10922857 0.78 PDE7A (0.45) CHRNA7SMN1; SMN2HTR2A
SCHEMBL11219447 0.77 CHRNA7 (0.44) DRD1DRD2DRD5DRD3DRD4
SCHEMBL10471907 0.76 DRD1 (0.44) DRD1DRD2DRD5DRD3DRD4
SCHEMBL11167029 0.75 ADRA2A (0.47) DRD1DRD2DRD5DRD3DRD4
Bromide SCHEMBL11159318 0.75 DRD1 (0.47) DRD1DRD2DRD5DRD3DRD4
SCHEMBL10925142 0.74 ADRA2A (0.49) DRD1DRD2DRD5DRD4CHRNA7
SCHEMBL10700283 0.72 DRD1 (0.49) DRD1DRD2DRD5DRD3DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback